← Back to Search

Behavioral Intervention

Mobile Text Messaging Support for Smoking Cessation

N/A
Waitlist Available
Led By Patricia Chalela, DrPH
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month and 3 months
Awards & highlights

Summary

This trial tests Quitxt, a mobile program that sends supportive texts and chat messages to help young Latino adults quit smoking. The study focuses on this group because they have high smoking rates and face significant health risks. Quitxt aims to boost users' confidence and skills to quit smoking through culturally relevant messages. Text messaging programs on mobile phones have shown some promise in helping people quit smoking.

Who is the study for?
This study is for Latino young adults aged 18-29 who smoke at least one cigarette a day, want to quit smoking, own a cell phone with text and internet capabilities, and can provide follow-up data. They should not be in another cessation program or planning to move from the study area during the trial.
What is being tested?
The Quitxt research study tests a mobile text messaging intervention designed to help young Latino adults stop smoking. Participants are randomly assigned to receive either interactive Quitxt messages or standard texts with cessation content plus referral to an existing state health service program.
What are the potential side effects?
Since this trial involves text messaging interventions for smoking cessation rather than medication, there are no direct medical side effects. However, participants may experience typical nicotine withdrawal symptoms such as irritability, cravings, or difficulty concentrating.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month and 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Smoking cessation
Secondary study objectives
Smoking cessation assessment

Trial Design

2Treatment groups
Experimental Treatment
Group I: Usual careExperimental Treatment1 Intervention
Abbreviated text messaging with smoking cessation-related content and referral to the Texas Department of State Health Services (TDSHS) cessation program Yes Quit (www.yesquit.org) available to smokers seeking help quitting. The abbreviated text messaging will include general information on smoking harms and benefits of cessation, and baseline data collection and follow-up assessments.
Group II: Quitxt bilingual text messaging and chatExperimental Treatment1 Intervention
Culturally and linguistically tailored, bilingual text messaging or chat mobile app. Our text messaging or chat intervention will include messaging options in which users can text or message a code when they are craving a cigarette or at risk of relapse and immediately receive text or social media messages to help them avoid smoking. The social media content also will include opportunities for users to repeatedly visit key content pages and receive immediate support when experiencing cravings, stress, bad mood, or when feeling at risk of smoking.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Interactive, bilingual, and culturally tailored mobile messaging interventions, like those studied in the Quitxt trial, work by providing personalized support and motivation to quit smoking. These messages often include educational content, coping strategies, and reminders to stay on track, which help patients manage cravings and reinforce their commitment to quit. The cultural tailoring ensures that the content is relevant and resonates with the patient's background, increasing engagement and effectiveness. This matters for smoking cessation patients because it addresses both the psychological and social aspects of addiction, making it more likely for them to succeed in quitting smoking.
An international survey: Tobacco smoking cessation strategies within left ventricular assist device centers.Mobile phone-based messaging for tobacco cessation in low and middle-income countries: A systematic review.Culturally-tailored text-messaging intervention for smoking cessation in rural American Indian communities: Rationale, design, and methods.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center at San AntonioLead Sponsor
471 Previous Clinical Trials
90,689 Total Patients Enrolled
Cancer Prevention Research Institute of TexasOTHER
52 Previous Clinical Trials
97,744 Total Patients Enrolled
The University of Texas at San AntonioOTHER
22 Previous Clinical Trials
6,304 Total Patients Enrolled

Media Library

Quitxt (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05958667 — N/A
Smoking Cessation Research Study Groups: Quitxt bilingual text messaging and chat, Usual care
Smoking Cessation Clinical Trial 2023: Quitxt Highlights & Side Effects. Trial Name: NCT05958667 — N/A
Quitxt (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05958667 — N/A
~800 spots leftby Aug 2028